Childhood sarcoidosis in the middle Anatolia of Turkey.
childhood
noncaseating granuloma
sarcoidosis
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
26
05
2023
received:
31
10
2022
accepted:
10
06
2023
medline:
21
8
2023
pubmed:
21
6
2023
entrez:
21
6
2023
Statut:
ppublish
Résumé
This retrospective study aimed to describe the clinical and radiological features, diagnostic methods, laboratory findings, organ involvement, and treatment strategies of 22 patients who followed up with late-onset childhood sarcoidosis and compare them with the literature. This retrospective multicenter study reviewed the medical records of 22 children with sarcoidosis who applied to the Pediatric pulmonology department of Erciyes University Faculty of Medicine and Necmettin Erbakan Faculty of Medicine in 2012 and 2022. The mean age of the patients at the time of diagnosis was 13.1/year (interquartile range [IQR]1:6.3-[IQR]3:15.7). The most common first presenting symptom was cough 40.9% (n = 9), weight loss 31.8% (n = 7), and dyspnea 22.7% (n = 5). There were elevated levels of C-reactive protein (CRP; 59%), angiotensin-converting enzyme (ACE; 54.5%), erythrocyte sedimentation rate (ESR; 54.5%), and immunoglobulin G (IgG; 54.5%). Twenty patients (90%) received systemic steroid treatment. Eighteen (81.8%) of these patients responded positively to treatment. Two patients had a recurrence. The incidence of sarcoidosis in children in Turkey is currently unknown. However, a regional average of 2.2 cases per year has been documented for the first time. Contrary to previous studies, a significant prevalence of consanguineous marriage was observed in our study. While constitutional symptoms were most common in other studies, the cough was the most common symptom in our study. To our knowledge, this is one of the Turkish studies with the highest number of sarcoidosis in children and one of the few European studies on sarcoidosis in children.
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2619-2627Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Shetty AK, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol. 2008;6:16.
Shetty AK, Gedalia A. Sarcoidosis in children. Curr Probl Pediatr. 2000;30:153-176.
Spagnolo P, Grunewald J. Recent advances in the genetics of sarcoidosis. J Med Genet. 2013;50:290-297.
Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153-2165.
Pattishall EN, Kendig Jr. EL. Sarcoidosis in children. Pediatr Pulmonol. 1996;22:195-203.
Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-755.
Miller MR. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149-173.
Sève P, Pacheco Y, Durupt F, et al. Sarcoidosis: A clinical overview from symptoms to diagnosis. Cells. 2021;10:766.
Kiper N, Anadol D, Ouzçelik U, Göçmen A. Inhaled corticosteroids for maintenance treatment in childhood pulmonary sarcoidosis. Acta Paediatr (Stockholm). 2001;90:953-956.
Nathan N, Marcelo P, Houdouin V, et al. Lung sarcoidosis in children: update on disease expression and management. Thorax. 2015;70:537-542.
Gedalia A, Khan TA, Shetty AK, Dimitriades VR, Espinoza LR. Childhood sarcoidosis: Louisiana experience. Clin Rheumatol. 2016;35:1879-1884.
Hoffmann A, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr (Stockholm). 2004;93:30-36.
Nathan N, Sileo C, Calender A, et al. Paediatric sarcoidosis. Paediatr Respir Rev. 2019;29:53-59.
Fetil E, Ozkan S, Ilknur T, Kavukcu S, Kusku E, Lebe B. Sarcoidosis in a preschooler with only skin and joint involvement. Pediatr Dermatol. 2003;20:416-418.
Shetty AK, Gedalia A. Sarcoidosis: a pediatric perspective. Clin Pediatr. 1998;37:707-717.
Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol. 2014;12:33.
Gorkem SB, Köse S, Lee EY, Doğanay S, Coskun AS, Köse M. Thoracic MRI evaluation of sarcoidosis in children. Pediatr Pulmonol. 2017;52(4):494-499.
Fauroux B, Clément A. Paediatric sarcoidosis. Paediatr Respir Rev. 2005;6:128-133.
Bénéteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J. Serum angiotensin-converting enzyme in healthy and sarcoidotic children: comparison with the reference interval for adults. Clin Chem. 1990;36:344-346.